APA (7th ed.) Citation

Torre, A., Martínez‐Sánchez, F. D., Narvaez‐Chávez, S. M., Herrera‐Islas, M. A., Aguilar‐Salinas, C. A., & Córdova‐Gallardo, J. (2024). Pirfenidone use in fibrotic diseases: What do we know so far? Immunity, Inflammation & Disease, 12(7), 1. https://doi.org/10.1002/iid3.1335

Chicago Style (17th ed.) Citation

Torre, Aldo, Froylan David Martínez‐Sánchez, Sofía Mercedes Narvaez‐Chávez, Mariana Ariel Herrera‐Islas, Carlos Alberto Aguilar‐Salinas, and Jacqueline Córdova‐Gallardo. "Pirfenidone Use in Fibrotic Diseases: What Do We Know so Far?" Immunity, Inflammation & Disease 12, no. 7 (2024): 1. https://doi.org/10.1002/iid3.1335.

MLA (9th ed.) Citation

Torre, Aldo, et al. "Pirfenidone Use in Fibrotic Diseases: What Do We Know so Far?" Immunity, Inflammation & Disease, vol. 12, no. 7, 2024, p. 1, https://doi.org/10.1002/iid3.1335.